Mitochondrial YBX1 promotes cancer cell metastasis by inhibiting pyruvate uptake

Abstract

Pyruvate is an essential fuel for maintaining the tricarboxylic acid (TCA) cycle in the mitochondria. However, the precise molecular mechanism of pyruvate uptake by mitochondrial pyruvate carrier (MPC) is largely unknown. Here, we report that the DNA/RNA-binding protein Y-box binding protein 1 (YBX1) is localized to the mitochondrial inter-membrane space by its C-terminal domain (CTD) in cancer cells. In mitochondria, YBX1 inhibits pyruvate uptake by associating with MPC1/2, thereby suppressing pyruvate-dependent TCA cycle flux. This association, in turn, promotes MPC-mediated glutaminolysis and histone lactylation. Our findings reveal that the YBX1-MPC axis exhibits a positive correlation with metastatic potential, while does not affect cell proliferation in both cultured cells and tumor xenografts. Therefore, the restricted pyruvate uptake into mitochondria potentially represents a hallmark of metastatic capacity, suggesting that the YBX1-MPC axis is a therapeutic target for combating cancer metastasis.

Keywords

mitochondria / YBX1 / pyruvate metabolism / MPC1/2 / metastasis

References

[1] Jeoung NH, Harris CR, Harris RA. Regulation of pyruvate metabolism in metabolic-related diseases. Rev Endocr Metab Disord 2014;15:99–110.

[2] Olson KA, Schell JC, Rutter J. Pyruvate and metabolic flexibility: illuminating a path toward selective cancer therapies. Trends Biochem Sci 2016;41:219–30.

[3] Koppenol WH, Bounds PL, Dang CV. Otto Warburg’s contributions to current concepts of cancer metabolism. Nat Rev Cancer 2011;11:325–37.

[4] Luengo A, Li Z, Gui DY et al. Increased demand for NAD⁺ relative to ATP drives aerobic glycolysis. Mol Cell 2021;81:691–707.e6.

[5] Bricker DK, Taylor EB, Schell JC et al. A mitochondrial pyruvate carrier required for pyruvate uptake in yeast, Drosophila, and humans. Science 2012;337:96–100.

[6] Herzig S, Raemy E, Montessuit S et al. Identification and functional expression of the mitochondrial pyruvate carrier. Science 2012;337:93–6.

[7] Schell JC, Olson KA, Jiang L et al. A role for the mitochondrial pyruvate carrier as a repressor of the Warburg effect and colon cancer cell growth. Mol Cell 2014;56:400–13.

[8] Flores A, Schell J, Krall AS et al. Lactate dehydrogenase activity drives hair follicle stem cell activation. Nat Cell Biol 2017;19:1017–26.

[9] Schell JC, Wisidagama DR, Bensard C et al. Control of intestinal stem cell function and proliferation by mitochondrial pyruvate metabolism. Nat Cell Biol 2017;19:1027–36.

[10] Kim J, Yu L, Chen W et al. Wild-type p53 promotes cancer metabolic switch by inducing PUMA-dependent suppression of oxidative phosphorylation. Cancer Cell 2019;35:191–203.e8.

[11] Vanderperre B, Cermakova K, Escoffier J et al. MPC1-like is a placental mammal-specific mitochondrial pyruvate carrier subunit expressed in postmeiotic male germ cells. J Biol Chem 2016;291:16448–61.

[12] Zangari J, Petrelli F, Maillot B et al. The multifaceted pyruvate metabolism: role of the mitochondrial pyruvate carrier. Biomolecules 2020;10:1068.

[13] Compan V, Pierredon S, Vanderperre B et al. Monitoring mitochondrial pyruvate carrier activity in real time using a BRET-based biosensor: investigation of the Warburg effect. Mol Cell 2015;59:491–501.

[14] Bensard CL, Wisidagama DR, Olson KA et al. Regulation of tumor initiation by the mitochondrial pyruvate carrier. Cell Metab 2020;31:284–300.e7.

[15] Muthusamy T, Cordes T, Handzlik MK et al. Serine restriction alters sphingolipid diversity to constrain tumour growth. Nature 2020;586:790–5.

[16] Liu X, Chen D, Chen H et al. YB1 regulates miR-205/200b-ZEB1 axis by inhibiting microRNA maturation in hepatocellular carcinoma. Cancer Commun (Lond) 2021;41:576–95.

[17] Chen X, Li A, Sun BF et al. 5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs. Nat Cell Biol 2019;21:978–90.

[18] El-Naggar AM, Veinotte CJ, Cheng H et al. Translational activation of HIF1α by YB-1 promotes sarcoma metastasis. Cancer Cell 2015;27:682–97.

[19] Coles LS, Lambrusco L, Burrows J et al. Phosphorylation of cold shock domain/Y-box proteins by ERK2 and GSK3β and repression of the human VEGF promoter. FEBS Lett 2005;579:5372–8.

[20] Lu ZH, Books JT, Ley TJ. YB-1 is important for late-stage embryonic development, optimal cellular stress responses, and the prevention of premature senescence. Mol Cell Biol 2005;25:4625–37.

[21] Jayavelu AK, Schnöder TM, Perner F et al. Splicing factor YBX1 mediates persistence of JAK2-mutated neoplasms. Nature 2020;588:157–63.

[22] Evdokimova V, Tognon C, Ng T et al. Translational activation of snail1 and other developmentally regulated transcription factors by YB-1 promotes an epithelial-mesenchymal transition. Cancer Cell 2009;15:402–15.

[23] Rabiee A, Plucińska K, Isidor MS et al. White adipose remodeling during browning in mice involves YBX1 to drive thermogenic commitment. Mol Metab 2021;44:101137.

[24] Xu L, Li H, Wu L et al. YBX1 promotes tumor growth by elevating glycolysis in human bladder cancer. Oncotarget 2017;8:65946–56.

[25] de Souza-Pinto NC, Mason PA, Hashiguchi K et al. Novel DNA mismatch-repair activity involving YB-1 in human mitochondria. DNA Repair (Amst) 2009;8:704–19.

[26] Jady BE, Ketele A, Kiss T. Dynamic association of human mRNP proteins with mitochondrial tRNAs in the cytosol. RNA 2018;24:1706–20.

[27] Matsumoto S, Uchiumi T, Saito T et al. Localization of mRNAs encoding human mitochondrial oxidative phosphorylation proteins. Mitochondrion 2012;12:391–8.

[28] Cho NH, Cheveralls KC, Brunner AD et al. OpenCell: endogenous tagging for the cartography of human cellular organization. Science 2022;375:eabi6983.

[29] Huttlin EL, Bruckner RJ, Navarrete-Perea J et al. Dual proteome- scale networks reveal cell-specific remodeling of the human interactome. Cell 2021;184:3022–40.e28.

[30] van Roeyen CR, Scurt FG, Brandt S et al. Cold shock Y-box protein- 1 proteolysis autoregulates its transcriptional activities. Cell Commun Signal 2013;11:63.

[31] Dietmair S, Hodson MP, Quek LE et al. A multi-omics analysis of recombinant protein production in Hek293 cells. PLoS One 2012;7:e43394.

[32] Henry O, Jolicoeur M, Kamen A. Unraveling the metabolism of HEK-293 cells using lactate isotopomer analysis. Bioprocess Biosyst Eng 2011;34:263–73.

[33] Buescher JM, Antoniewicz MR, Boros LG et al. A roadmap for interpreting ¹³C metabolite labeling patterns from cells. Curr Opin Biotechnol 2015;34:189–201.

[34] Boese AC, Kang S. Mitochondrial metabolism-mediated redox regulation in cancer progression. Redox Biol 2021;42:101870.

[35] Yang L, Venneti S, Nagrath D. Glutaminolysis: a hallmark of cancer metabolism. Annu Rev Biomed Eng 2017;19:163–94.

[36] Vacanti NM, Divakaruni AS, Green CR et al. Regulation of substrate utilization by the mitochondrial pyruvate carrier. Mol Cell 2014;56:425–35.

[37] Yang C, Ko B, Hensley CT et al. Glutamine oxidation maintains the TCA cycle and cell survival during impaired mitochondrial pyruvate transport. Mol Cell 2014;56:414–24.

[38] Gao P, Tchernyshyov I, Chang TC et al. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 2009;458:762–5.

[39] Wise DR, DeBerardinis RJ, Mancuso A et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc Natl Acad Sci U S A 2008;105:18782–7.

[40] Feng M, Xie X, Han G et al. YBX1 is required for maintaining myeloid leukemia cell survival by regulating BCL2 stability in an m⁶A-dependent manner. Blood 2021;138:71–85.

[41] Liu S, Marneth AE, Alexe G et al. The kinases IKBKE and TBK1 regulate MYC-dependent survival pathways through YB-1 in AML and are targets for therapy. Blood Adv 2018;2:3428–42.

[42] Bommert KS, Effenberger M, Leich E et al. The feed-forward loop between YB-1 and MYC is essential for multiple myeloma cell survival. Leukemia 2013;27:441–50.

[43] Bott AJ, Peng IC, Fan Y et al. Oncogenic Myc induces expression of glutamine synthetase through promoter demethylation. Cell Metab 2015;22:1068–77.

[44] Dichtl S, Lindenthal L, Zeitler L et al. Lactate and IL6 define separable paths of inflammatory metabolic adaptation. Sci Adv 2021;7:eabg3505.

[45] Zhang D, Tang Z, Huang H et al. Metabolic regulation of gene expression by histone lactylation. Nature 2019;574:575–80.

[46] Takaoka Y, Konno M, Koseki J et al. Mitochondrial pyruvate carrier 1 expression controls cancer epithelial-mesenchymal transition and radioresistance. Cancer Sci 2019;110:1331–9.

[47] Ohashi T, Eguchi H, Kawamoto K et al. Mitochondrial pyruvate carrier modulates the epithelial-mesenchymal transition in cholangiocarcinoma. Oncol Rep 2018;39:1276–82.

[48] Ha B, Lee EB, Cui J et al. YB-1 overexpression promotes a TGF-β1-induced epithelial-mesenchymal transition via Akt activation. Biochem Biophys Res Commun 2015;458:347–51.

[49] Matsumoto S, Uchiumi T, Tanamachi H et al. Ribonucleoprotein Y-box-binding protein-1 regulates mitochondrial oxidative phosphorylation (OXPHOS) protein expression after serum stimulation through binding to OXPHOS mRNA. Biochem J 2012;443:573–84.

[50] Rath S, Sharma R, Gupta R et al. MitoCarta3.0: an updated mitochondrial proteome now with sub-organelle localization and pathway annotations. Nucleic Acids Res 2021;49:D1541–7.

[51] Jobard E, Pontoizeau C, Blaise BJ et al. A serum nuclear magnetic resonance-based metabolomic signature of advanced metastatic human breast cancer. Cancer Lett 2014;343:33–41.

[52] Torrino S, Grasset EM, Audebert S et al. Mechano-induced cell metabolism promotes microtubule glutamylation to force metastasis. Cell Metab 2021;33:1342–57.e10.

[53] Bergers G, Fendt SM. The metabolism of cancer cells during metastasis. Nat Rev Cancer 2021;21:162–80.

[54] Najumudeen AK, Ceteci F, Fey SK et al. The amino acid transporter SLC7A5 is required for efficient growth of KRAS-mutant colorectal cancer. Nat Genet 2021;53:16–26.

[55] Tasdogan A, Faubert B, Ramesh V et al. Metabolic heterogeneity confers differences in melanoma metastatic potential. Nature 2020;577:115–20.

[56] Chen P, Zuo H, Xiong H et al. Gpr132 sensing of lactate mediates tumor-macrophage interplay to promote breast cancer metastasis. Proc Natl Acad Sci U S A 2017;114:580–5.

[57] Collot M, Wattiaux-De Coninck S, Wattiaux R. Deterioration of rat-liver mitochondria during isopycnic centrifugation in an isoosmotic medium. Eur J Biochem 1975;51:603–8.

[58] Machado AM, Desler C, Bøggild S et al. Helicobacter pylori infection affects mitochondrial function and DNA repair, thus, mediating genetic instability in gastric cells. Mech Ageing Dev 2013;134:460–6.

[59] Wittig I, Braun HP, Schagger H. Blue native PAGE. Nat Protoc 2006;1:418–28.

[60] Liu Z, Yang S, Zhou L et al. Structural characterization of protein-material interfacial interactions using lysine reactivity profiling-mass spectrometry. Nat Protoc 2023;18:2600–23.

[61] Cox J, Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies, and proteome-wide protein quantification. Nat Biotechnol 2008;26:1367–72.

[62] Yan M, Qi H, Xia T et al. Metabolomics profiling of metformin- mediated metabolic reprogramming bypassing AMPKα. Metabolism 2019;91:18–29.

[63] Millard P, Delépine B, Guionnet M et al. IsoCor: isotope correction for high-resolution MS labeling experiments. Bioinformatics 2019;35:4484–7.

[64] Frezza C, Cipolat S, Scorrano L. Organelle isolation: functional mitochondria from mouse liver, muscle, and cultured fibroblasts. Nat Protoc 2007;2:287–95.

[65] Chen WW, Freinkman E, Wang T et al. Absolute quantification of matrix metabolites reveals the dynamics of mitochondrial metabolism. Cell 2016;166:1324–37.e11.

[66] Yang C, Ko B, Hensley CT et al. Glutamine oxidation maintains the TCA cycle and cell survival during impaired mitochondrial pyruvate transport. Mol Cell 2014;56:414–24.

RIGHTS & PERMISSIONS

2023 The Author(s) 2023. Published by Oxford University Press on behalf of Higher Education Press.